Abstract
Background
The most practical measure to augment the available number of liver grafts and thus reduce waiting list mortality is to increase the donor age limit. We hypothesized that with careful selection of old liver donors without age limit it should be possible to obtain good patient and graft survival.
Methods
The present study comprises 351 adults who underwent liver transplantation. They were divided into three groups according to the age of the liver donors: group 1: 226 recipients of donors <60 years; group 2: 75 recipients of donors between 60 and 70 years; and group 3: 50 recipients of donors >70 years. A comparative study among the groups was performed.
Results
Patient survival rates at 1, 3, and 5 years were, respectively, 81.0, 76.1, and 71.1 % in group 1; 83.8, 74, and 72.2 % in group 2; and 76, 70.0, and 62.9 % in group 3 (P = NS). Graft survival at 1, 3, and 5 years was, respectively, 74.8, 69.0, and 64.1 % in group 1; 82.7, 71.4, and 69.6 % in group 2; and 71.4, 64.8, and 58.3 % in group 3 (P = NS). We analyzed the use of older grafts in recipients with HCV cirrhosis and did not find significant differences in patient and graft survival at 1, 3, and 5 years. In multivariate analysis increased donor body mass index and decreased recipient albumin were associated with lower patient and graft survival.
Conclusions
Because patient and graft survival rates are not affected by donor age, well-selected older donor livers can be safely used if they show good function and preharvesting conditions.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- CI:
-
Confidence interval
- CIT:
-
Cold ischemia time
- FFP:
-
Fresh frozen plasma
- GGT:
-
Gamma-glutamyl transpeptidase
- GOT:
-
Glutamic oxaloacetic transaminase
- GPT:
-
Glutamic pyruvic transaminase
- HBV:
-
Hepatitis B virus
- HCC:
-
Hepatocarcinoma
- HCV:
-
Hepatitis C virus
- HR:
-
Hazard ratio
- ICU:
-
Intensive care unit
- IPF:
-
Initial poor function
- OLT:
-
Ortothopic liver transplantation
- PNF:
-
Primary nonfunction
- PRBC:
-
packed red blood cells
- WIT:
-
Warm ischemia time
References
ONT (2008) Memoria de Actividades de la ONT 2008 (1ª Parte). Trasplante hepático. Revista Española de Trasplantes 18:32–50
Strasberg SM, Howard TK, Molmenti EP et al (1994) Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 20:829–838
Adam R, Sánchez C, Astarcioglu I et al (1995) Deleterious effect of extended cold ischemia time on the posttransplant outcome of aged livers. Transplant Proc 27:1181–1183
Ureña MA, Ruiz-Delgado FC, González EM et al (1998) Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program. Transplant Proc 30:3288–3291
López-Navidad A, Caballero F (2003) Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool. Clin Transplant 17:308–324
Busuttil RW, Tanaka K (2003) The utility of marginal donors in liver transplantation. Liver Transpl 9:651–663
Yersiz H, Renz JF, Farmer DG et al (2003) One-hundred in situ split-liver transplantations: a single center experience. Ann Surg 238:496–505
Renz JF, Kin C, Kinkhabwala M et al (2005) Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation. Ann Surg 242:556–565
Tector AJ, Mangus RS, Chestovich P et al (2006) Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg 244:439–450
Bernat JL, D’Alessandro AM, Port FK et al (2006) Report of a National Conference on Donation after cardiac death. Am J Transplant 6:281–291
Marino IR, Doyle HR, Doria C et al (1995) Outcome of liver transplantation using donors 60 to 79 years of age. Transplant Proc 27:1184–1185
Emre S, Schwartz ME, Altaca G et al (1996) Safe use of hepatic allograft from donors older than 70 years. Transplantation 62:62–65
Cescon M, Grazi GL, Ercolani G et al (2003) Long-term survival of recipients of liver grafts from donors older than 80 years: is it achievable? Liver Transpl 9:1174–1180
Anderson CD, Vachharajani N, Doyle M et al (2008) Advanced donor age alone does not affect patient or graft survival after liver transplantation. J Am Coll Surg 207:847–852
Ravaioli M, Grazi GL, Cescon M et al (2009) Liver transplantations with donors aged 60 years and above: the low liver damage strategy. Transplant Int 22:423–433
Marino IR, Doyle HR, Aldrighetti L et al (1995) Effect of donor age and sex on the outcome of liver transplantation. Hepatology 22:1754–1762
Hoofnagle JH, Lombardero M, Zetterman RK et al (1996) Donor age and outcome of liver transplantation. Hepatology 24:89–96
Busquets J, Xiol X, Figueras J et al (2001) The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation 71:1765–1771
Moore DE, Feurer ID, Speroff T et al (2005) Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation. Arch Surg 140:273–277
Grande L, Matus D, Rimola A et al (1998) Expanded liver donor age over 60 years for liver transplantation. Clin Transplant 12:297–301
Rodríguez F, Jiménez C, Romano D et al (2002) Orthotopic liver transplantation with 100 hepatic allografts from donors over 60 years old. Transplant Proc 34:233–234
Gastaca M, Valdivieso A, Pijoan J et al (2005) Donors older than 70 years in liver transplantation. Transplant Proc 37:3851–3854
Zapletal C, Faust D, Wullstein C et al (2005) Does the liver ever age? Results of liver transplantation with donors above 80 years of age. Transplant Proc 37:1182–1185
Segev DR, Maley WR, Simpkins CE et al (2007) Minimizing risk associated with elderly liver donors by matching to preferred recipients. Hepatology 46:1907–1918
Jiménez C, Manrique A, Marqués E et al (2007) Incidence and risk factors for the development of lung tumors after liver transplantation. Transplant Int 20:57–63
Feng S, Goodrich NP, Bragg-Gresham JL et al (2006) Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 6:783–790
Rinella ME, Alonso E, Rao S et al (2001) Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl 7:409–414
Greig PD, Forster J, Superina RA et al (1990) Donor-specific factors predict graft function following liver transplantation. Transplant Proc 22:2072–2073
Markin RS, Wisecarver JL, Radio SJ et al (1993) Frozen section evaluation of donor livers before transplantation. Transplantation 56:1403–1409
Karayalcin K, Mirza DF, Harrison RF et al (1994) The role of dynamic and morphological studies in the assessment of potential liver donors. Transplantation 57:1323–1327
García-Ureña MA, Colina F, Moreno E et al (1998) Hepatic steatosis in liver transplant donors: common feature of donor population? World J Surg 22:837–844. doi:10.1007/s002689900479
Adam R, Astarcioglu I, Azoulay D et al (1991) Age greater than 50 years is not a contraindication for liver donation. Transplant Proc 23:2602–2603
D’Alessandro AM, Kalayoglu M, Sollinger HW et al (1991) The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation. Transplantation 51:157–163
Fishbein TM, Fiel MI, Emre S et al (1997) Use of livers with microvesicular fat safely expands the donor pool. Transplantation 64:248–251
Verran D, Kusyk T, Painter D et al (2003) Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 9:500–505
Briceño J, Pera-Rojas C, Lluch M et al (2001) Intraoperative assessment of liver transplantation with marginal liver grafts. Transplant Proc 33:903–905
Briceño J, Marchal T, Padillo J et al (2002) Influence of marginal donors on liver preservation injury. Transplantation 74:522–526
Wall WJ (1999) Predicting outcome after liver transplantation. Liver Transpl Surg 5:458–459
Jiménez C, Moreno E, Colina F et al (1999) Use of octogenarian livers safely expands the donor pool. Transplantation 68:572–576
Nardo B, Masetti M, Urbani L et al (2004) Liver transplantation from donors aged 80 years and over: pushing the limit. Am J Transplant 4:1139–1147
Cescon M, Mazziotti A, Grazi GL et al (2001) Evaluation of the use of graft livers procured from old donors (70 to 87 years) for hepatic transplantation. Transplant Proc 33:934–935
Cuende N, Grande L, Sanjuan F et al (2002) Liver transplant with organs from elderly donors: Spanish experience with more than 300 liver donors over 70 years of age. Transplantation 73:1360
Kim DY, Cauduro SP, Bohorquez HE et al (2005) Routine use of livers from deceased donors older than 70: is it justified? Transplant Int 18:73–77
Fouzas I, Sgourakis G, Nowak KM et al (2008) Liver transplantation with grafts from septuagenarians. Transplant Proc 40:3198–3200
Piratvisuth T, Tredger JM, Hayllar KA et al (1995) Contribution of true cold and rewarming ischemia times to factors determining outcome after orthotopic liver transplantation. Liver Transpl Surg 1:296–301
Cameron AM, Ghobrial RM, Yersiz H et al (2006) Optimal utilization of donor grafts with extended criteria. A single-center experience in over 1000 liver transplants. Ann Surg 243:748–755
Ghobrial RM, Gornbein J, Steadman R et al (2002) Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg 236:315–322
Berenguer M, Prieto M, San Juan F et al (2002) Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 36:202–210
Wali M, Harrison RF, Gow PJ et al (2002) Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 51:248–252
Russo MW, Galanko JA, Zacks SL et al (2004) Impact of donor age and year of transplant on graft survival in liver transplant recipients with chronic hepatitis C. Am J Transplant 4:1133–1138
Lake JR, Shorr JS, Steffen BJ et al (2005) Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant 5:549–557
Condron SL, Heneghan MA, Patel K et al (2005) Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection. Transplantation 80:145–148
Mutimer DL, Gunson B, Chen J (2006) Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation 81:7–14
Iacob S, Cicinnati VR, Hilgard P et al (2007) Predictors of graft and patient survival in hepatitis C virus (HCV) recipients: model to predict HCV cirrhosis after liver transplantation. Transplantation 84:56–63
Machicao VI, Bonatti H, Krishna M et al (2004) Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 77:84–92
Rayhill SC, Wu YM, Katz DA et al (2007) Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C. Transplantation 84:331–339
Yersiz H, Shaked A, Olthoff K et al (1995) Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation 60:790–794
Winger DJ, Sponsilli EE (1977) Concentrations of serum protein fractions in white women: effects of age, weight, smoking, tonsillectomy and other factors. Clin Chem 23:1310–1317
Shepherd AM, Hewick DS, Moreland TA et al (1977) Age as a determinant of sensitivity to warfarin. Br J Pharmacol 4:315–320
Ploeg RJ, D’Alessandro AM, Knechtle SJ et al (1993) Risk factors for primary dysfunction after liver transplantation: a multivariate analysis. Transplantation 55:807–813
Mueller AP, Platz KP, Krause P et al (1999) Is the use of marginal liver grafts justified? Transplant Proc 31:401–402
Stewart ZA, Locke JE, Segev DL et al (2009) Increased risk of graft loss from hepatic artery thrombosis after liver transplantation with older donors. Liver Transpl 15:1688–1695
Deschenes M, Forbes C, Tchervenkov J et al (1999) Use of older donor livers is associated with more extensive ischemic damage on intraoperative biopsies during liver transplantation. Liver Transpl Surg 5:357–361
Busuttil RW, Farmer DG, Yersiz H et al (2005) Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single center experience. Ann Surg 241:905–916
Doyle M, Anderson C, Vachharajani N et al (2008) Liver transplantation for hepatitis C virus. Effect of using older donor grafts on short- and medium-term survival. Arch Surg 143:679–685
Acknowledgments
The authors thank Javier de la Cruz and David Lora for contributions to the statistical analysis. We also thank Dr. M. Abradelo, Dr. F. Cambra, and Dr. F. Colina for collaboration in this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jiménez-Romero, C., Clemares-Lama, M., Manrique-Municio, A. et al. Long-Term Results Using Old Liver Grafts for Transplantation: Sexagenerian Versus Liver Donors Older than 70 Years. World J Surg 37, 2211–2221 (2013). https://doi.org/10.1007/s00268-013-2085-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-013-2085-7